Social Media Ideas for Drug Approval

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Datroway]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Ennumo]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Hepcludex]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Xocova]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Utebzi and Capvaxive]]>

<![CDATA[EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval]]>

On second try, Acadia drug gets nod from European regulators

The influential CHMP committee also threw its support behind more than a dozen other medicines while recommending the marketing authorization for Tavneos be revoked.

<![CDATA[FDA Approves Leqembi Iqlik Subcutaneous Injection for Early Alzheimer’s Disease]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Subcutaneous Formulation of Leqembi Iqlik]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Subcutaneous Sarclisa Escena]]>

Depression Drug Approved by FDA Had 11 Failed Trials and an Advisory Committee Vote Against Approval

Rejected by the FDA four times; an advisory committee vote against approval. Yet in 2023, gepirone (Exxua) was approved for depression. The post Depression Drug Approved by FDA Had...

<![CDATA[FDA Sends CRL to Cingulate for CTx-1301]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Baxdrostat]]>

<![CDATA[FDA Approves Subcutaneous Sarclisa Escena for Multiple Myeloma ]]>

<![CDATA[FDA Accepts NDA for Giredestrant in ER-Positive Early-Stage Breast Cancer]]>

<![CDATA[FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhi...

<![CDATA[FDA Approves Hepcludex as First and Only Approved Treatment for Chronic Hepatitis Delta Virus]]>

<![CDATA[FDA Issues CRL to Elevar Therpaeutics for Combination of Rivoceranib and Camrelizumab ]]>

Replimune takes third swing at cancer drug approval following ‘productive’ FDA talks

A twice-spurned therapy that’s been seen as one of the FDA’s more controversial recent rejections is getting a new chance following the resignation of former commissioner Marty Mak...

HepQuant nabs FDA premarket approval for liver diagnostic test

The FDA has granted premarket approval to HepQuant’s liver diagnostic test for the treatment of adults with Child-Pugh Class A compensated cirrhosis, according to a company press r...

<![CDATA[Pharmaceutical Executive Daily: FDA Sends Complete Response Letter for Cingulate's CTx-1301]]>

Praxis faces FDA decision delay as analysts point finger at agency layoffs

The FDA has delayed a decision on the approval of Praxis Precision Medicine’s rare epilepsy prospect by three months. TD Cowen analysts said they “strongly believe FDA bandwidth co...

China’s National Medical Products Administration Releases Implementation Measures for Drug Trial Data Protection – May 3...

On May 15, 2026, China’s National Medical Products Administration (NMPA) released the Implementation Measures for Drug Trial Data Protection (药品试验数据保护实施办法), effective M...

<![CDATA[Pharmaceutical Executive Daily: FDA has Approved Skinvive by Juvéderm]]>